Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1767 of 5804
-
AI lends a hand in the operating room to stop bleeding faster
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if an artificial intelligence (AI) system that identifies bleeding points in real time can help stop bleeding faster during endoscopic submucosal dissection (ESD) - a minimally invasive surgery for early digestive tract cancer or precan…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Prostate cancer disparities: uncovering the hidden drivers
Knowledge-focused Recruiting nowProstate Cancer (PC) is the most common non-cutaneous malignancy diagnosed and second leading cause of cancer death among men across the United States. PC among Black men accounts for a higher proportion alike of cancer diagnoses and deaths. In the prostate specific antigen (PSA)…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
New schizophrenia drug shows promise in Long-Term safety trial
Disease control Recruiting nowML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants with schizophrenia who have recently completed an antecedent study (ML-007C-MA-211) or enroll directly (De Novo Cohort).
Phase: PHASE2 • Sponsor: MapLight Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study investigates brain fog after CAR-T and bispecific antibody therapies
Knowledge-focused Not yet recruitingCell- and antibody-based therapies, including chimeric antigen receptor T-cell (CAR-T) therapy and bispecific antibodies, represent significant advances in the treatment of hematologic malignancies. These therapies optimise the patient's immune system to target and eliminate mali…
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Light-Based brain scan could revolutionize diagnosis of rare genetic disorders
Diagnosis Recruiting nowFragile X syndrome (FXS, OMIM #300624) and Creatine Transporter Deficiency (CTD, #300352) are the two most common causes of X-linked intellectual disability. FXS and CTD affect hemizygous males and with highly variable severity heterozygous females. Both these neurodevelopmental …
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
New blood filter could save lives in severe pancreatitis
Disease control Recruiting nowThe goal of the study is to evaluate the safety and efficacy of multimodal (cytokine and lipopolysaccharide) hemoperfusion using the Efferon® LPS device in combination with hemofiltration (HF) / hemodiafiltration (HDF), with the goal of reducing the severity of organ dysfunction …
Phase: NA • Sponsor: Efferon JSC • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Heart scarring over time: new study aims to predict sudden death risk in HCM patients
Knowledge-focused Recruiting nowThis study aims to learn what might predict heart problems (like sudden death from a fast heart rhythm or heart failure) in people with a genetic condition called hypertrophic cardiomyopathy (HCM). HCM causes the heart muscle to become thick, which can make the heart stiff and ha…
Sponsor: Christopher Kramer • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Lung cancer study: which targeted drug works best for rare mutation?
Disease control Not yet recruitingIn a retrospective analysis of 3,054 advanced NSCLC patients, 41 with EGFR exon 19 deletion-insertions (19delins) received first-generation EGFR TKIs, achieving median PFS of 10.4 months; those with L747\_T751delinsP had notably longer PFS of 18.7 months. Another study of 2,467 t…
Phase: EARLY_PHASE1 • Sponsor: Fuzhou General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New laser probe could spot stomach cancer earlier than biopsy
Diagnosis Not yet recruitingThe pathological biopsy of gastric lesions, performed prior to endoscopic submucosal dissection (ESD), is crucial for differentiating the pathological nature of the lesions and guiding treatment decisions. However, due to the impact of biopsy sampling, the sensitivity of the path…
Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
New study aims to predict who will survive acute liver failure
Knowledge-focused Not yet recruitingAcute liver failure (ALF) is a rare but life-threatening condition with high mortality. Despite advances in supportive care and liver transplantation, prognosis varies significantly across etiologies, particularly in patients with indeterminate causes. This study aims to investi…
Sponsor: Li-Ying Sun • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
5,000-Patient study to unlock immunotherapy secrets for lymph node cancer
Knowledge-focused Not yet recruitingLymph node metastasis is a key stage of malignant tumor progression and a core factor affecting the efficacy of immunotherapy. The therapeutic response of lymph node metastases to immune checkpoint inhibitors (ICIs) varies significantly among different cancer types, and the under…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Could less lymph node surgery be better for High-Risk prostate cancer?
Disease control Recruiting nowBALANCE is a multicenter, prospective, randomized controlled trial enrolling men with unilateral high-risk localized prostate cancer identified by prostate biopsy, multiparametric MRI, and PSMA PET imaging. Eligible patients scheduled for robot-assisted radical prostatectomy will…
Phase: NA • Sponsor: University of Turin, Italy • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
10-year study tracks how often LunaXT breast implants break or harden
Disease control Recruiting nowThe goal of this observational, non-comparative study is to determine the frequency and rate of rupture and capsular contracture Baker III-IV of Eurosilicone Luna range of breast implants, over a 10-year period following surgical implantation in female population between 18 and 6…
Sponsor: GCA (Eurosilicone) • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a simple CO2 test save lives in septic shock?
Knowledge-focused Recruiting nowSepsis is a dysregulated host response to infection that leads to life-threatening organ dysfunction and represents a major healthcare problem. Septic shock is the most severe form, characterized by increased capillary permeability and vasodilation, resulting in hypotension and t…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New camera tech could spot cervical lesions better than current method
Diagnosis Not yet recruiting1. Primary Objective: To compare the diagnostic accuracy of high-definition electronic magnifying endoscopy combined with image-enhanced technology versus colposcopy for cervical and vaginal lesions. 2. Secondary Objectives: To evaluate and compare the sensitivity, specifici…
Phase: NA • Sponsor: West China Second University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
New diabetes pill icovamenib enters Mid-Stage trial
Disease control Recruiting nowThis is a Phase 2, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes who are not achieving glycemic targets despite antihyperglycemic medications.
Phase: PHASE2 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New psychotherapy may ease chronic pain in veterans
Symptom relief Recruiting nowThe goal of this clinical trial is to learn which treatment works better for veterans with chronic neck or back pain. This study is comparing three treatments: Pain Reprocessing Therapy (PRT), Cognitive Behavioral Therapy (CBT), and usual care (whatever a person is already doing …
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New Stent-Graft device under scrutiny for treating dangerous aortic aneurysms
Disease control Recruiting nowTo evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug APSTZD aims to improve sleep in insomnia patients
Symptom relief Not yet recruitingThe purpose of this study is to evaluate the efficacy of APSTZD compared to one active drug and placebo in insomnia treatment.
Phase: PHASE2 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New pill aims to keep narcolepsy patients awake and safe
Symptom relief Recruiting nowThe primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of excessive daytime sleepiness (EDS) as assessed by Mean Sleep Latency (MSL) (measured from the first 4 maintenance of wakefulness tests …
Phase: PHASE2 • Sponsor: Eisai Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC